ANNA K WIEGNER
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family COLUMBIA, SC NPI 1275921124
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family SC ABBVIE INC. All categories
General Payments — all program years on this page
$319.43
- Category: General Payments
- Program years: PY2021–2023
- Record count: 19
- As of (CMS publication): 2026-01-23
Latest program year (PY2023): $148.30 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2023) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $148.30 | 8 |
By paying entity
Latest program year (PY2023) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $45.15 | 3 |
| DEXCOM, INC. | $34.23 | 1 |
| Lilly USA, LLC | $29.19 | 2 |
| Novo Nordisk AS | $24.75 | 1 |
| Abbott Laboratories | $14.98 | 1 |
By program year
Records — PY2023 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1002009139 | Novo Nordisk Inc | $24.75 | 02/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1010226963 | ABBVIE INC. | $14.21 | 02/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1010226967 | ABBVIE INC. | $14.89 | 05/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1010226971 | ABBVIE INC. | $16.05 | 11/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1019057547 | Abbott Laboratories | $14.98 | 03/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1032709611 | Lilly USA, LLC | $14.52 | 03/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1032749221 | Lilly USA, LLC | $14.67 | 03/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1054908579 | Dexcom, Inc. | $34.23 | 06/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.